Cash & equivalents decreased 24.3%
Cash & equivalents changed -24.3% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$263.6M→$199.4M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MANH financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 22.1%
Trade receivables changed +22.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$219.6M→$268.1M4 prior comparisons
Current liabilities increased 19.9%
Current liabilities changed +19.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$400.4M→$480.1M4 prior comparisons
Working capital / assets moved 1194 bp lower
Working capital / assets changed -1194 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
16.31%→4.37%4 prior comparisons
Operating cash flow decreased 26.3%
Operating cash flow changed -26.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$93.1M→$68.6M2 prior comparisons
Working capital decreased 73.8%
Working capital changed -73.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$125.4M→$32.8M4 prior comparisons
Free-cash-flow proxy decreased 22.5%
Free-cash-flow proxy changed -22.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$87.2M→$67.6M2 prior comparisons
Shares outstanding decreased 3.6%
Shares outstanding changed -3.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
60,258,247→58,061,8938 prior comparisons
Current ratio decreased 18.6%
Current ratio changed -18.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1.31→1.074 prior comparisons
Capital expenditure decreased 83.3%
Capital expenditure changed -83.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$5.9M→$991,0002 prior comparisons
Operating margin moved 104 bp lower
Operating margin changed -104 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.49%→26.45%2 prior comparisons
Capex / revenue moved 183 bp lower
Capex / revenue changed -183 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.15%→0.32%2 prior comparisons
Free-cash-flow margin moved 953 bp lower
Free-cash-flow margin changed -953 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
31.61%→22.08%2 prior comparisons
Operating cash-flow margin moved 1136 bp lower
Operating cash-flow margin changed -1136 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
33.76%→22.40%2 prior comparisons
Revenue increased 11.0%
Revenue changed +11.0% from the comparable as-filed period.
$275.8M→$306.2M2 prior comparisons
Receivables / revenue moved 796 bp higher
Receivables / revenue changed +796 basis points from the comparable as-filed period.
79.61%→87.56%2 prior comparisons
Operating income increased 6.8%
Operating income changed +6.8% from the comparable as-filed period.
$75.8M→$81.0M2 prior comparisons
Stock-based compensation increased 24.1%
Stock-based compensation changed +24.1% from the comparable as-filed period.
$27.6M→$34.2M2 prior comparisons
Gross margin moved 37 bp higher
Gross margin changed +37 basis points from the comparable as-filed period.
56.56%→56.93%2 prior comparisons
Operating cash flow / net income decreased 29.6%
Operating cash flow / net income changed -29.6% from the comparable as-filed period.
1.59→1.122 prior comparisons
SBC / revenue moved 118 bp higher
SBC / revenue changed +118 basis points from the comparable as-filed period.
10.00%→11.17%2 prior comparisons
Net income increased 4.6%
Net income changed +4.6% from the comparable as-filed period.
$58.6M→$61.3M2 prior comparisons
Cost of revenue increased 10.1%
Cost of revenue changed +10.1% from the comparable as-filed period.
$119.8M→$131.9M2 prior comparisons
Research & development decreased 2.2%
Research & development changed -2.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$36.4M→$35.5M2 prior comparisons
R&D / revenue moved 158 bp lower
R&D / revenue changed -158 basis points from the comparable as-filed period.
13.18%→11.61%2 prior comparisons
Total assets decreased 2.3%
Total assets changed -2.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$768.8M→$750.8M4 prior comparisons
Current assets decreased 2.4%
Current assets changed -2.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$525.8M→$512.9M4 prior comparisons
Current liabilities increased 16.7%
Current liabilities changed +16.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$407.2M→$475.1M4 prior comparisons
Working capital / assets moved 1137 bp lower
Working capital / assets changed -1137 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
10.23%→-1.14%4 prior comparisons
Operating margin moved 485 bp lower
Operating margin changed -485 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
27.09%→22.24%2 prior comparisons
Free-cash-flow proxy increased 28.0%
Free-cash-flow proxy changed +28.0% from the comparable as-filed period.
$70.1M→$89.7M3 prior comparisons
Cash & equivalents decreased 19.3%
Cash & equivalents changed -19.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$230.6M→$186.1M4 prior comparisons
Working capital changed across a sign change
Working capital changed -110.5% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
$76.2M→-$8.0M4 prior comparisons
Operating cash flow increased 22.5%
Operating cash flow changed +22.5% from the comparable as-filed period.
$74.1M→$90.7M3 prior comparisons
Shares outstanding decreased 3.6%
Shares outstanding changed -3.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
60,468,594→58,304,9728 prior comparisons
Current ratio decreased 17.2%
Current ratio changed -17.2% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
1.19→0.984 prior comparisons
Capital expenditure decreased 74.7%
Capital expenditure changed -74.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$4.0M→$1.0M3 prior comparisons
Operating income decreased 10.2%
Operating income changed -10.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$73.8M→$66.2M2 prior comparisons
Receivables / revenue moved 353 bp lower
Receivables / revenue changed -353 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
77.03%→73.50%2 prior comparisons
Gross margin moved 81 bp lower
Gross margin changed -81 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
57.34%→56.53%2 prior comparisons
Revenue increased 9.3%
Revenue changed +9.3% from the comparable as-filed period.
$272.4M→$297.8M2 prior comparisons
Free-cash-flow margin moved 439 bp higher
Free-cash-flow margin changed +439 basis points from the comparable as-filed period.
25.72%→30.11%2 prior comparisons
Operating cash-flow margin moved 327 bp higher
Operating cash-flow margin changed +327 basis points from the comparable as-filed period.
27.18%→30.45%2 prior comparisons
Net income decreased 11.3%
Net income changed -11.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$56.8M→$50.4M2 prior comparisons
Operating cash flow / net income increased 38.1%
Operating cash flow / net income changed +38.1% from the comparable as-filed period.
1.3→1.82 prior comparisons
Capex / revenue moved 112 bp lower
Capex / revenue changed -112 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.46%→0.34%2 prior comparisons
Total assets decreased 6.2%
Total assets changed -6.2% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$744.7M→$698.6M4 prior comparisons
Stock-based compensation increased 20.9%
Stock-based compensation changed +20.9% from the comparable as-filed period.
$24.3M→$29.4M3 prior comparisons
SBC / revenue moved 95 bp higher
SBC / revenue changed +95 basis points from the comparable as-filed period.
8.91%→9.86%2 prior comparisons
Current assets decreased 3.4%
Current assets changed -3.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$483.3M→$467.1M4 prior comparisons
Cost of revenue increased 11.4%
Cost of revenue changed +11.4% from the comparable as-filed period.
$116.2M→$129.5M2 prior comparisons
Trade receivables increased 4.3%
Trade receivables changed +4.3% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$209.8M→$218.9M4 prior comparisons
Research & development decreased 0.3%
Research & development changed -0.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$34.9M→$34.8M2 prior comparisons
R&D / revenue moved 113 bp lower
R&D / revenue changed -113 basis points from the comparable as-filed period.
12.80%→11.67%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.